RU94042022A - Medicinal agent for brain ischemia treatment - Google Patents

Medicinal agent for brain ischemia treatment

Info

Publication number
RU94042022A
RU94042022A RU94042022/14A RU94042022A RU94042022A RU 94042022 A RU94042022 A RU 94042022A RU 94042022/14 A RU94042022/14 A RU 94042022/14A RU 94042022 A RU94042022 A RU 94042022A RU 94042022 A RU94042022 A RU 94042022A
Authority
RU
Russia
Prior art keywords
brain
succinate
blood supply
medicinal agent
brain ischemia
Prior art date
Application number
RU94042022/14A
Other languages
Russian (ru)
Other versions
RU2108095C1 (en
Inventor
А.С. Саратиков
В.А. Хазанов
М.Н. Кондрашова
Ю.М. Гольдберг
Original Assignee
Акционерное общество закрытого типа - Промышленно-финансовая компания "Внедрение"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное общество закрытого типа - Промышленно-финансовая компания "Внедрение" filed Critical Акционерное общество закрытого типа - Промышленно-финансовая компания "Внедрение"
Priority to RU94042022A priority Critical patent/RU2108095C1/en
Publication of RU94042022A publication Critical patent/RU94042022A/en
Application granted granted Critical
Publication of RU2108095C1 publication Critical patent/RU2108095C1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: clinical pharmacology. SUBSTANCE: the known substance ammonium succinate is proposed as agent for correction of blood supply and brain metabolism. Ammonium succinate provides increase of brain blood supply, antihypoxic and antiacidotic actions and normalizes succinate-dependent energy production by brain mitochondrions. EFFECT: enhanced effectiveness of patient treatment.

Claims (1)

Изобретение относится к клинической фармакологии и может быть использовано для лечения ишемического повреждения мозга. С целью повышения эффективности лечения больных с ишемией мозга предлагается использовать известное вещество янтарнокислый аммоний по новому назначению - в качестве корректора нарушений кровоснабжения и метаболизма мозга. Противоишемический эффект янтарнокислого аммония обусловлен увеличением кровоснабжения мозга, антигипоксическим и антиацидотическим действием, препарат нормализует сукцинатзависимую энергопродукцию митохондрий мозга.The invention relates to clinical pharmacology and can be used to treat ischemic brain damage. In order to increase the effectiveness of treatment of patients with cerebral ischemia, it is proposed to use the well-known substance ammonium succinic acid for a new purpose - as a corrector of circulatory disorders and brain metabolism. The anti-ischemic effect of ammonium succinic acid is due to an increase in blood supply to the brain, antihypoxic and antacidotic effects, the drug normalizes the succinate-dependent energy production of brain mitochondria.
RU94042022A 1994-11-22 1994-11-22 Medicinal preparation for curing cerebral ischemia RU2108095C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94042022A RU2108095C1 (en) 1994-11-22 1994-11-22 Medicinal preparation for curing cerebral ischemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94042022A RU2108095C1 (en) 1994-11-22 1994-11-22 Medicinal preparation for curing cerebral ischemia

Publications (2)

Publication Number Publication Date
RU94042022A true RU94042022A (en) 1996-10-20
RU2108095C1 RU2108095C1 (en) 1998-04-10

Family

ID=20162596

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94042022A RU2108095C1 (en) 1994-11-22 1994-11-22 Medicinal preparation for curing cerebral ischemia

Country Status (1)

Country Link
RU (1) RU2108095C1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002379B1 (en) * 1999-07-21 2002-04-25 Российский Государственный Педагогический Университет Им. А.И.Герцена Remedy having anti-ischemic, antihypoxic and hypotensive activities
WO2003055476A1 (en) * 2001-12-25 2003-07-10 Pomytkin Igor A Use of succinic acid and salts thereof for inhibiting platelet aggregation
RU2545833C1 (en) * 2013-12-03 2015-04-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПХФА Минздрава России) Pharmaceutical composition with anti-ischemic and antioxidant activity and method for preparing it

Also Published As

Publication number Publication date
RU2108095C1 (en) 1998-04-10

Similar Documents

Publication Publication Date Title
DE68902649D1 (en) LOCAL MEDICINAL PRODUCT FOR TREATING INFLAMMATORY DISEASES.
KR900700089A (en) Pharmaceutical Compositions for Systemic Skin Permeable Administration
DE69815122D1 (en) SACCHARID-CONTAINING PREPARATIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES
ATE388700T1 (en) THERAPEUTIC COMPOSITIONS OF VENOUS DILATORS AND ARTERIAL DILATORS
DE69327328D1 (en) USE OF NORASTEMIZOL FOR THE TREATMENT OF ALLERGIC RHINITIS
DE60115432D1 (en) APOPTOTIC BODIES FOR USE IN THE TREATMENT OF T-CELL MEDICAMENT AND INFLAMMATORY DISEASES
KR910005858A (en) Fatty acid therapy
DE60129322D1 (en) APOPTOTIC BODIES FOR USE IN THE TREATMENT OF NEURODE GENERATIVE AND OTHER NERVE DISEASES
RU94042022A (en) Medicinal agent for brain ischemia treatment
NO153495C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE MORPHANTRIDIN DERIVATIVES.
KR930019224A (en) Abortion Hazard Remedy
DE69943240D1 (en) Use of HGF for the treatment of limb ischemic disorders
Fazio et al. Treatment of Parkinson's disease with l-DOPA and an association l-DOPA plus a DOPA decarboxylase inhibitor
SE0000258D0 (en) Pharmaceutical preparation and method of treatment of diabetes
JPS6442423A (en) Remedy containing propaphenone antipode
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
SU110747A1 (en) Method of treating trichomonas diseases
RU2256434C2 (en) Method for closing tympanic membrane perforation
NO20013480L (en) Dry skin medicine
SU1136798A1 (en) Method of treatment of hyperactive behavour
SU1487907A1 (en) Method of treating ovular paints
SU564865A1 (en) Method for treating patients having vegetative form of polyneuritis with concomitant diseases
RU2002113429A (en) METHOD FOR TREATING PSORIASIS
RU94035493A (en) Method for treating diskal lumbosacral and other types of intervertebral hernias
JPS60208907A (en) Hair growth stimulant